研報掘金丨山西證券:杭叉集團25Q1超預期增長,首予“增持-A”評級
山西證券研報指出,杭叉集團(603298.SH)2024年歸母淨利潤20.22億元,同比+17.86%;25Q1歸母淨利潤4.36億元,同比+15.18%。盈利能力穩步提升,2024年銷售淨利率創歷史最佳;25Q1超預期增長。公司持續優化海外佈局,海外營銷和製造並舉。此外,公司還將推進研發人形智能物流機器人,加大AI 在物流行業的應用。當前叉車行業高端化、數智化、綠色化、國際化速度日益加快,公司作爲行業頭部企業有望憑藉品牌效應、規模經濟、技術研發、品質與服務等獲得更大的競爭優勢,實現集中度提升。首次覆蓋給予“增持-A”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.